中文 | English
Return
Total: 108 , 1/11
Show Home Prev Next End page: GO
Author:( Xiaolin SHI)

1.Evaluation of Taraxacum mongolicum Germplasm Resources Based on Characteristic Profiles and Chemical Markers

Lantian SHI ; Xiaojie LIU ; Xiaolin LI ; Yutong HUA

Chinese Journal of Experimental Traditional Medical Formulae 2026;32(7):267-275

2.Anti-osteoporosis Effect of Isorhamnetin: A Review

Shilong MENG ; Xu ZHANG ; Yawei XU ; Yang YU ; Wei LI ; Yanguang CAO ; Xiaolin SHI ; Wei ZHANG ; Kang LIU

Chinese Journal of Experimental Traditional Medical Formulae 2025;31(5):347-352

3.DTLCDR:A target-based multimodal fusion deep learning framework for cancer drug response prediction

Jie YU ; Cheng SHI ; Yiran ZHOU ; Ningfeng LIU ; Xiaolin ZONG ; Zhenming LIU ; Liangren ZHANG

Journal of Pharmaceutical Analysis 2025;15(8):1825-1836

4.Construction of predictive model for programmed death-1 inhibitor-related endocrine adverse events

Jiaying SHI ; Wei WEI ; Ting HAN ; Xiao ZHOU ; Meng ZHUO ; Xiaolin LIN ; Tao TAO ; Xiuying XIAO

Chinese Journal of Clinical Medicine 2025;32(4):551-560

5.Isokinetic sensorimotor training can improve hand function after a stroke

Jiang MA ; Yu LIU ; Hong LI ; Wanying SHI ; Xiaolin TAO ; Bei ZUO

Chinese Journal of Physical Medicine and Rehabilitation 2025;47(6):499-505

6.Construction of China’s bio-health narrative system: enhancement of narrative ecology and national bio-health narrative consciousness

Xiaolin YANG ; Fengqi SU ; Yahui WANG ; Peiyao SHI

Chinese Medical Ethics 2025;38(6):745-750

7.Trends analysis of pancreatic cancer mortality in Xuhui district, Shanghai from 1992 to 2021

Jingshu XU ; Jianhua SHI ; Haiyan GU ; Lei CHEN ; Xiaolin QIAN ; Lu LU ; Deng NIU

Journal of Surgery Concepts & Practice 2025;30(1):34-40

8.In-depth development of artificial intelligence in pathological diagnosis:from addressing challenges to reshaping the future

Min SHI ; Ying CHEN ; Xiaodong WANG ; Xiaolin ZHANG ; Guanzhen YU

Academic Journal of Naval Medical University 2025;46(11):1387-1393

9.DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction.

Jie YU ; Cheng SHI ; Yiran ZHOU ; Ningfeng LIU ; Xiaolin ZONG ; Zhenming LIU ; Liangren ZHANG

Journal of Pharmaceutical Analysis 2025;15(8):101315-101315

10.Comparison of the prognostic value of 15 nutritional/inflammatory indicators in postoperative cancer patients

Xiaoqian LIU ; Kai SUN ; Xiaolin WANG ; Qianqian ZHAO ; Xiaoxiao WU ; Fangqi SHEN ; Xi CHEN ; Chenxu TIAN ; Di WU ; Chunhua SONG ; HongXia XU ; Minghua CONG ; Hanping SHI ; Pingping JIA

Journal of Capital Medical University 2025;46(3):410-419

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 108 , 1/11 Show Home Prev Next End page: GO